AI Stock Finder
Loading...
Skip to main content
Model output · Signal date Oct. 15, 2026

Daily Signals

2567 companies scored · 2026-10-15 run in progress: 4899 of ~5380 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-15 Cut-offs from the 2026-10-15 run
Companies scored 2567 IC ≥ 0 · market cap ≥ $100M
Median forecast +2.95% Total · 90D
Long–short spread +5.51% Strong Buy minus Strong Sell, mean
Median IC 0.28 Spearman · 90D
Rating changes ▲ 187 ▼ 270 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · All

2567 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1501 CNXCConcentrix Corp Trade & Services 0.20 $1.6B Unlock rating and forecasts
1502 CNOBConnectOne Bancorp, Inc. Finance 0.06 $1.6B Neutral +0.84% +2.59% ▼ 1
1503 ZBIOZenas BioPharma, Inc. Life Sciences 0.17 $1.6B Unlock rating and forecasts
1504 BFCBank First Corp Finance 0.31 $1.6B Unlock rating and forecasts
1505 AVEXAEVEX Corp. Manufacturing 0.59 $1.6B Unlock rating and forecasts
1506 GLOBGlobant S.A. Technology 0.25 $1.6B Neutral +1.05% +2.46% ·
1507 OMCLOMNICELL, INC. Technology 0.52 $1.6B Neutral +0.75% +2.77% ·
1508 KOSKosmos Energy Ltd. Energy & Transportation 0.51 $1.6B Neutral +0.57% +2.21% ·
1509 ATECAlphatec Holdings, Inc. Industrial Applications and Services 0.19 $1.6B Unlock rating and forecasts
1510 NOMDNomad Foods Ltd Manufacturing 0.42 $1.6B Neutral +0.81% +2.17% ·
1511 CTSCTS CORP Manufacturing 0.10 $1.6B Neutral +0.64% +2.30% ·
1512 NVCRNovoCure Ltd Industrial Applications and Services 0.51 $1.6B Unlock rating and forecasts
1513 ANIPANI PHARMACEUTICALS INC Life Sciences 0.60 $1.6B Unlock rating and forecasts
1514 GENBGenerate Biomedicines, Inc. Life Sciences 0.10 $1.6B Unlock rating and forecasts
1515 HUBGHub Group, Inc. Energy & Transportation 0.30 $1.6B Unlock rating and forecasts
1516 NTLAIntellia Therapeutics, Inc. Life Sciences 0.49 $1.6B Unlock rating and forecasts
1517 WBWEIBO Corp Technology 0.13 $1.6B Unlock rating and forecasts
1518 LOBLive Oak Bancshares, Inc. Finance 0.25 $1.6B Unlock rating and forecasts
1519 QCRHQCR HOLDINGS INC Finance 0.10 $1.6B Neutral +0.68% +3.01% ·
1520 LILALiberty Latin America Ltd. Technology 0.43 $1.6B Unlock rating and forecasts
1521 GSHDGoosehead Insurance, Inc. Finance 0.53 $1.6B Neutral +1.30% +3.35% ·
1522 EFOREverforth Inc Trade & Services 0.36 $1.6B Neutral +0.58% +2.07% ·
1523 OCULOCULAR THERAPEUTIX, INC Life Sciences 0.16 $1.6B Neutral +1.73% +2.51% ·
1524 OBKOrigin Bancorp, Inc. Finance 0.54 $1.6B Neutral +0.98% +2.88% ·
1525 KEELKeel Infrastructure Corp. Finance or Crypto Assets 0.14 $1.6B Unlock rating and forecasts
1526 CMPSCOMPASS Pathways plc Life Sciences 0.35 $1.6B Unlock rating and forecasts
1527 DEIDouglas Emmett Inc Real Estate & Construction 0.00 $1.6B Neutral +0.69% +2.29% ▲ 1
1528 STCSTEWART INFORMATION SERVICES CORP Finance 0.30 $1.6B Neutral +0.95% +3.09% ·
1529 PAHCPHIBRO ANIMAL HEALTH CORP Life Sciences 0.47 $1.5B Neutral +0.66% +2.46% ·
1530 RVLVRevolve Group, Inc. Trade & Services 0.45 $1.5B Neutral +0.83% +2.97% ·
1531 CCSCentury Communities, Inc. Real Estate & Construction 0.17 $1.5B Neutral +1.02% +3.05% ·
1532 BANDBandwidth Inc. Technology 0.06 $1.5B Unlock rating and forecasts
1533 HYMCHYCROFT MINING HOLDING CORP Energy & Transportation 0.36 $1.5B Unlock rating and forecasts
1534 OCFCOCEANFIRST FINANCIAL CORP Finance 0.13 $1.5B Neutral +0.71% +3.10% ·
1535 JSMNAVIENT CORP Finance 0.14 $1.5B Unlock rating and forecasts
1536 INVAInnoviva, Inc. Life Sciences 0.43 $1.5B Unlock rating and forecasts
1537 ETONEton Pharmaceuticals, Inc. Life Sciences 0.10 $1.5B Unlock rating and forecasts
1538 EFCEllington Financial Inc. Real Estate & Construction 0.46 $1.5B Unlock rating and forecasts
1539 ENRENERGIZER HOLDINGS, INC. Manufacturing 0.31 $1.5B Unlock rating and forecasts
1540 STOKStoke Therapeutics, Inc. Life Sciences 0.40 $1.5B Neutral +1.37% +3.35% ▼ 1
1541 ABSIAbsci Corp Industrial Applications and Services 0.10 $1.5B Unlock rating and forecasts
1542 HLFHERBALIFE LTD. Trade & Services 0.56 $1.5B Neutral +0.81% +2.12% ·
1543 CBLCBL & ASSOCIATES PROPERTIES INC Real Estate & Construction 0.09 $1.5B Neutral +0.92% +2.53% ▲ 1
1544 ALKTALKAMI TECHNOLOGY, INC. Technology 0.36 $1.5B Unlock rating and forecasts
1545 DMLPDORCHESTER MINERALS, L.P. Energy & Transportation 0.38 $1.5B Unlock rating and forecasts
1546 PRKSUnited Parks & Resorts Inc. Trade & Services 0.18 $1.5B Neutral +1.31% +2.87% ·
1547 RAREUltragenyx Pharmaceutical Inc. Life Sciences 0.35 $1.5B Unlock rating and forecasts
1548 AGLagilon health, inc. Industrial Applications and Services 0.01 $1.5B Unlock rating and forecasts
1549 JJSFJ&J SNACK FOODS CORP Manufacturing 0.18 $1.5B Unlock rating and forecasts
1550 TFINTriumph Financial, Inc. Finance 0.40 $1.5B Neutral +0.86% +2.77% ·
1501–1550 of 2567 Previous Next
Since the previous run

Rating changes

▲ 187▼ 270
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-15) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.